Stockmarket

Inspira Technologies Signs a Strategic Agreement With Waas Group




By Sam Boughedda

Investing.com — Medical device maker Inspira Technologies Oxy BHN Ltd (NASDAQ:) announced Tuesday that it has signed an exclusive distribution agreement with Anita Técnica S.L. (WAAS Group).

WAAS Group is a distributor and technical service provider of medical equipment and supplies in Spain.

The news sent Inspira shares flying over 200%, to $7.50 — an all time high for the stock since its initial public offering in July.

The agreement has an initial seven-year term and will see the companies collaborate on the marketing and deployment of the ART device, a respiratory support system designed to treat deteriorating respiratory failure patients while they are awake and breathing. 

Inspira said the device has the potential to reduce the need for mechanical ventilation across Spain and Portugal.

As part of the deal, WAAS Group is committed to purchasing a minimum of 1040 ART devices and 35,360 disposable units within seven years. 

“Portugal and Spain are important markets in Europe that have extensive experience operating extracorporeal technologies. We see this as an advantage in ensuring the rapid penetration and adoption of our innovative ART device by the local medical community,” said Joe Hayon, Inspira Technologies’ Co-Founder, President and Chief Financial Officer.

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.